D
CRISPR Therapeutics AG CRSP
$41.86 $3.298.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -136.00M -37.31M -85.94M -126.41M -116.59M
Total Depreciation and Amortization 4.74M 4.84M 4.74M 4.85M 4.83M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 22.47M 6.79M 14.65M 15.49M 11.02M
Change in Net Operating Assets 54.85M -24.35M -40.36M 10.49M 210.49M
Cash from Operations -53.95M -50.03M -106.91M -95.58M 109.75M
Capital Expenditure -206.00K -254.00K -219.00K -707.00K -721.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -19.55M 106.08M -161.39M -126.20M -97.08M
Cash from Investing -19.76M 105.83M -161.60M -126.91M -97.80M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 10.59M 16.88M 9.64M -- 305.93M
Repurchase of Common Stock -- -- -- -466.00K --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 10.59M 16.88M 9.64M -466.00K 305.93M
Foreign Exchange rate Adjustments 41.00K -87.00K 75.00K 2.00K -11.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -63.07M 72.59M -258.80M -222.95M 317.88M